Clinical Instructor, Department of Neurology
The goal of this study is to change the standard of care for AD patients by determining the added value of an individualized care management program for Alzheimer?s patients receiving memantine. Subjects with moderate to severe AD are eligible. All patients will be randomly assigned to one of two groups. Patients in both groups will receive memantine and follow up evaluations at no cost to them. Additionally, one group will receive compensation and the other group will receive an individualized management program consisting of home visits to get the patient exercising, doing enjoyable activities, and cognitive stimulation, as well as support and training for caregivers. The duration of the study is seven months to one year. For information about participating in this program please contact Dr. Sunnie Kenowsky at 212 -263-7164, 212-371-6039 or by email at sunnie.kenowsky@nyumc.org
Clinical Instructor, Department of Neurology at NYU Grossman School of Medicine
Alzheimer's & dementia. 2022 Dec 01; 18(<prism:issueIdentifier>S8):?-?
Dementia geriatric & cognitive disorders. 2020 May 08; 1-6
Dementia geriatric & cognitive disorders. 2017 05; 43(1-2):100-117
Medical aspects of disability for the rehabilitation professionals. [New York] : Springer Publishing Company, 2017. 5th edition. p.?-?. (2558782)
Dementia geriatric & cognitive disorders. 2014 Jan; 38(1-2):89-146
Medical aspects of disability : a handbook for the rehabilitation professional. New York, NY, US: Springer Publishing Co, 2005. 3rd. ed. p.79-118. (4103)
International psychogeriatrics. 1999 Mar; 11(1):7-23